Zymeworks Inc.
Bispecific Asymmetric Heterodimers Comprising Anti-CD3 Constructs
Last updated:
Abstract:
Disclosed herein are isolated multi-specific heteromultimer constructs that bind to CD3 expressed on T-cells and to an antigen expressed on B-cells. The multi-specific heteromultimer constructs are capable of bridging T- and B-cells and mediating killing of B-cells. The multi-specific heteromultimer constructs are based on a heterodimeric Fc scaffold or on a segmented albumin scaffold. Also disclosed herein are multi-specific heteromultimer constructs that bind to HER2 and HER3.
Status:
Application
Type:
Utility
Filling date:
24 Jan 2019
Issue date:
15 Aug 2019